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Cutaneous leishmaniasis (CL) is an emerging disease 
in Sri Lanka. Of 116 patients with clinical symptoms sug-
gestive of CL, 86 were conﬁ  rmed positive for Leishmania 
donovani. Most patients had single dry lesions, usually on 
the face. Patients were from 5 of the 7 agroclimatic zones 
in Sri Lanka.  
Leishmaniasis is a complex of diseases that has 3 main 
clinical forms, visceral, mucocutaneous, and cutaneous. 
For decades in Sri Lanka, leishmaniasis was considered 
an exotic disease. This changed in 1992 with the detection 
of locally acquired cases of cutaneous leishmaniasis (CL) 
(1,2). In 2003, Karunaweera et al. (3) reported that CL in 
Sri Lanka is caused by the parasite Leishmania donovani 
zymodeme MON-37; however, information on other as-
pects of the disease in Sri Lanka was scant. We present 
preliminary ﬁ  ndings on the clinical manifestations and the 
distribution of CL in Sri Lanka.
The Study
The study group consisted of patients referred by their 
dermatologists from June 2001 through June 2005 for skin 
lesions clinically suggestive of CL. The patients were ex-
amined for conﬁ  rmatory diagnosis. Ethical clearance for 
the study was granted by the Research and Higher Degrees 
Committee of the Faculty of Medicine, University of Per-
adeniya, Sri Lanka.
Laboratory diagnosis was made by examination of Gi-
emsa-stained touch or impression smears, in vitro culture, 
and/or by PCR. Tissue samples for cultures and molecular 
testing were obtained by use of a hypodermic needle. Ev-
ans modiﬁ  ed Tobie medium was used for in vitro culture 
(4). PCR for diagnosis was performed on DNA extracted 
from tissue samples, by using a set of primers speciﬁ  c for 
all Old World Leishmania spp. (5).
Leishmania DNA from 27 patients positive for CL and 
from 5 in vitro cultures (promastigotes) was sent to Labo-
ratoire de Parasitologie, Besançon, France, for speciation. 
Characterization was performed by use of microsatellite 
analysis (also known as short tandem repeats), which used 
primers to amplify microsatellites in the internal transcribed 
spacer region of the Leishmania genomic DNA (6).
Of 120 patients examined, 4 had a history of travel 
overseas and were not included in the analysis. Of the re-
maining 116 patients, 86 (74.14%) were determined to be 
positive for CL. All but 2 of the 32 samples that were sent 
for speciation were identiﬁ  ed as L. donovani; the 2 that were 
not identiﬁ  ed did not have sufﬁ  cient DNA for testing.
At the time of study, patients had CL-related lesions 
ranging in duration from 2 weeks to 4 years. Both male and 
female patients were infected (ages range 3–70 years).
All infected patients had cutaneous lesions only; none 
showed hepatosplenomegaly or enlargement of lymph 
nodes. Single lesions were seen in 70 of the 86 patients, and 
multiple lesions (range 2–5) were observed in the other 16 
patients. Satellite lesions were seen in 11 of the 86 patients. 
Lesions appeared on the face of most patients (54.7%), but 
they also occurred in ears and on upper and lower limbs 
and the trunk (Table 1). No lesions were found from the 
waist to the knee.
The lesions on most patients were dry and scaly 
(69/86), but on some, they were wet (17/86). A few patients 
showed a hypopigmented halo around the lesions. Patients’ 
lesions were categorized according to their appearance: of 
the 86 patients, 25 had papulonodular lesions, 25 had nodu-
loulcerative lesions, and 36 had ulcerative lesions. Some 
ulcers had the typical volcanic appearance. 
The CL-infected patients came from 12 administrative 
districts (Figure), representing 8 of the country’s 9 provinces. 
The areas in which the patients lived were representative of 5 
of the 7 agroclimatic zones within Sri Lanka (Table 2). 
Conclusions
This study supports the earlier identiﬁ  cation (3) of L. 
donovani as the causative agent of CL in Sri Lanka. The 
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Table 1. Distribution of cutaneous leishmaniasis lesions on 
infected patients, Sri Lanka, June 2001–June 2005 
Location No. patients* %
Face 47 54.7
Scalp 1 1.2
Ear 5 5.8
Neck 3 3.5
Trunk 7 8.1
Upper limb 
Upper arm  4 4.7
Elbow 1 1.2
Forearm 22 25.6
Hand 2 2.3
Lower limb 
Above knee  0 0
Below knee  7 8.1
Foot 1 1.2
*Some had multiple lesions at different sites. Cutaneous Leishmaniasis, Sri Lanka
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27 isolates used in our study were from patients from 7 
districts (Kandy, Matale, Kurunegala, Anuradhapura, 
Vauniya, Trincomalee, and Jaffna) in 5 Sri Lankan prov-
inces (Central, North Central, North Western, Northern, 
and Eastern Provinces), representing different agroclimatic 
zones of the country. Thus, L. donovani appears to be the 
only species causing CL in Sri Lanka.
L. donovani usually causes visceral leishmaniasis, but 
there are other reports of it being associated with CL (7,8). A 
single parasite strain can cause different clinical symptoms 
(e.g., strains normally causing dermatotrophic symptoms in-
stead causing visceral symptoms and vice versa) (9,10).
In our study, 68% of the infected persons were 11–40 
years of age and frequently engaged in outdoor activities; 
similar ﬁ  ndings have been reported from Guatemala (11). 
In addition, for patients in our study, lesions most often ap-
peared on the face. Reports of CL from other countries and 
caused by different species have indicated similar ﬁ  ndings 
(8,12). Lesions also frequently occurred on the forearms of 
our study population, which suggests that uncovered areas 
of the body are more prone to clinical manifestation of CL 
infection. Sharma et al. (8) also reported that lesions most 
commonly appeared on the face and then the upper limbs; 
an earlier report from Sri Lanka showed extensor surfaces 
of the limbs to be the most common site for lesions (2). 
We also found skin lesions on the chest and back of some 
adult males; however, lesions did not occur in these sites 
on females. This ﬁ  nding is a direct reﬂ  ection of the cul-
tural habits related to clothing in Sri Lankan society. Also 
of interest, none of the patients had lesions in the area from 
below the waist to above the knees. This ﬁ  nding again is 
due to clothing habits. Dedet et al. (13), in their study on 
CL in French Guiana, found the distribution of lesions on 
the body to depend on the form of dress. One patient in our 
study group had a lesion on the scalp. This appears to be 
an unusual site, as hairy parts of the body were otherwise 
unaffected.
The lesions in our patients were slow-progressing, and 
58% appeared as papulonodular and noduloulcerative type 
lesions. A similar clinical picture was reported by Sharma 
et al. (8) in a study in which the researchers encountered 
noduloulcerative plaques with or without crusting. The 
morphologic appearance of lesions is known to vary de-
Figure. Geographic distribution of persons with cutaneous 
leishmaniasis in Sri Lanka during June 2001 through June 2005.
Table 2. Distribution of persons infected with cutaneous leishmaniasis in Sri Lanka, by agroclimatic zone, June 2001–June 2005 
Agricultural zone (elevation), climatic zone (rainfall/year)  Patient’s district*  No. patients  (N = 86) 
Up country (>900 m) 
  Wet (1,400 to >3,175 mm)  — 0
  Intermediate (1,150 to >2,160 mm)  — 0
Mid country (300–900 m) 
  Wet (1,270 to >3,175 mm)  Kandy  4
  Intermediate (900 to >1400 mm)  Kandy  2
Low country (<300 m) 
  Wet (1,525 to >2,540 mm)  Kegalle 2
Colombo 1
Galle 1
  Intermediate (900 to >1,150 mm)  Kurunegala 26
 Dry  (<900  mm)  Puttalam 2
Jaffna 3
Anuradhapura 7
Polonnaruwa 3
Vauniya 3
Trincomalee 11
Matale 7
*The districts of Kandy and Matale fall into 2 agroclimatic zones. DISPATCHES
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pending on the species or strain of the causative organism 
(13) and the immune status of the patient (14). 
Cutaneous nodules surrounded by areas of depigmen-
tation have been described in atypical CL due to L. chagasi 
(15). This feature was also found in 12 of our 86 patients. 
Thus, the clinical manifestations of CL vary; there is not a 
characteristic clinical picture for disease caused by a par-
ticular species.
Most of the CL patients in our study were from the 
dry and intermediate zones of the low-altitude areas of Sri 
Lanka. No cases of CL were diagnosed in persons from 
high-altitude areas. This could be due to the abundance of 
sandﬂ  ies (insect vectors for Leishmania) and their breeding 
sites in the low-altitude areas.
Since the ﬁ  rst detection of CL in Sri Lanka in 1992, the 
number of cases detected annually has increased (2,3). A 
substantial number of persons in our study had a diagnosis 
of CL, but the prevalence of infection in Sri Lanka could 
not be determined because the study did not involve active 
case detection. To understand the atypical behavior of L. 
donovani in Sri Lanka, studies need to be directed toward 
understanding the vector bionomics and reservoir hosts for 
this parasite.
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